Show simple item record

dc.contributor.authorYunes, Sarah A.en_US
dc.contributor.authorWilloughby, Jennifer L.S.en_US
dc.contributor.authorKwan, Julian H.en_US
dc.contributor.authorBiagi, Jessica M.en_US
dc.contributor.authorPokharel, Niranjanaen_US
dc.contributor.authorChin, Hang Gyeongen_US
dc.contributor.authorYork, Emily A.en_US
dc.contributor.authorSu, Kuan-Chungen_US
dc.contributor.authorGeorge, Kellyen_US
dc.contributor.authorShah, Jagesh V.en_US
dc.contributor.authorEmili, Andrewen_US
dc.contributor.authorSchaus, Scott E.en_US
dc.contributor.authorHansen, Ullaen_US
dc.contributor.editorPrigent, Claudeen_US
dc.coverage.spatialUnited Statesen_US
dc.date2022-05-09
dc.date.accessioned2023-08-07T16:57:53Z
dc.date.available2023-08-07T16:57:53Z
dc.date.issued2022
dc.identifierhttps://www.ncbi.nlm.nih.gov/pubmed/35704642
dc.identifierhttp://dx.doi.org/10.1371/journal.pone.0268857
dc.identifier.citationS.A. Yunes, J.L.S. Willoughby, J.H. Kwan, J.M. Biagi, N. Pokharel, H.G. Chin, E.A. York, K.-C. Su, K. George, J.V. Shah, A. Emili, S.E. Schaus, U. Hansen. 2022. "Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins." PLoS One, Volume 17, Issue 6, pp.e0268857-. https://doi.org/10.1371/journal.pone.0268857
dc.identifier.issn1932-6203
dc.identifier.urihttps://hdl.handle.net/2144/46519
dc.description.abstractFactor quinolinone inhibitors (FQIs), a first-in-class set of small molecule inhibitors targeted to the transcription factor LSF (TFCP2), exhibit promising cancer chemotherapeutic properties. FQI1, the initial lead compound identified, unexpectedly induced a concentration-dependent delay in mitotic progression. Here, we show that FQI1 can rapidly and reversibly lead to mitotic arrest, even when added directly to mitotic cells, implying that FQI1-mediated mitotic defects are not transcriptionally based. Furthermore, treatment with FQIs resulted in a striking, concentration-dependent diminishment of spindle microtubules, accompanied by a concentration-dependent increase in multi-aster formation. Aberrant γ-tubulin localization was also observed. These phenotypes suggest that perturbation of spindle microtubules is the primary event leading to the mitotic delays upon FQI1 treatment. Previously, FQIs were shown to specifically inhibit not only LSF DNA-binding activity, which requires LSF oligomerization to tetramers, but also other specific LSF-protein interactions. Other transcription factors participate in mitosis through non-transcriptional means, and we recently reported that LSF directly binds α-tubulin and is present in purified cellular tubulin preparations. Consistent with a microtubule role for LSF, here we show that LSF enhanced the rate of tubulin polymerization in vitro, and FQI1 inhibited such polymerization. To probe whether the FQI1-mediated spindle abnormalities could result from inhibition of mitotic LSF-protein interactions, mass spectrometry was performed using as bait an inducible, tagged form of LSF that is biotinylated by endogenous enzymes. The global proteomics analysis yielded expected associations for a transcription factor, notably with RNA processing machinery, but also to nontranscriptional components. In particular, and consistent with spindle disruption due to FQI treatment, mitotic, FQI1-sensitive interactions were identified between the biotinylated LSF and microtubule-associated proteins that regulate spindle assembly, positioning, and dynamics, as well as centrosome-associated proteins. Probing the mitotic LSF interactome using small molecule inhibitors therefore supported a non-transcriptional role for LSF in mediating progression through mitosis.en_US
dc.description.sponsorshipUL1 TR001430 - NCATS NIH HHS; R01 GM078240 - NIGMS NIH HHSen_US
dc.format.extentp. e0268857en_US
dc.format.mediumElectronic-eCollectionen_US
dc.languageeng
dc.language.isoen
dc.publisherPublic Library of Science (PLoS)en_US
dc.relation.ispartofPLoS One
dc.rights© 2022 Yunes et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectGeneral science & technologyen_US
dc.subject.meshMicrotubule-associated proteinsen_US
dc.subject.meshMicrotubulesen_US
dc.subject.meshMitosisen_US
dc.subject.meshQuinolonesen_US
dc.subject.meshSpindle apparatusen_US
dc.subject.meshTranscription factorsen_US
dc.subject.meshTubulinen_US
dc.titleFactor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteinsen_US
dc.typeArticleen_US
dc.date.updated2023-02-09T18:49:58Z
dc.description.versionPublished versionen_US
dc.identifier.doi10.1371/journal.pone.0268857
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/35704642
pubs.notesEmbargo: 12 monthsen_US
pubs.publication-statusPublished onlineen_US
pubs.publisher-urlhttp://dx.doi.org/10.1371/journal.pone.0268857
dc.date.online2022-06-15
dc.identifier.orcid0000-0001-8995-246X (Emili, Andrew)
dc.identifier.orcid0000-0001-9803-4185 (Hansen, Ulla)
dc.identifier.mycv756962


This item appears in the following Collection(s)

Show simple item record

© 2022 Yunes et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Except where otherwise noted, this item's license is described as © 2022 Yunes et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.